{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:01:08Z","timestamp":1784253668315,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","award":["U-99020"],"award-info":[{"award-number":["U-99020"]}],"id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejphar.2021.174615","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T11:03:46Z","timestamp":1638443026000},"page":"174615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial"],"prefix":"10.1016","volume":"914","author":[{"given":"Mojtaba","family":"Shohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roohangiz","family":"Nashibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Mahmoudian-Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Abolnezhadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Ghafourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaad","family":"Sharhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0442-273X","authenticated-orcid":false,"given":"Ali","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174615_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/1934578X20976293","article-title":"Quercetin: antiviral significance and possible COVID-19 integrative considerations","volume":"15","author":"Agrawal","year":"2020","journal-title":"Natural Product Communications"},{"key":"10.1016\/j.ejphar.2021.174615_bib2","series-title":"Evaluation of the Effect of Zinc, Quercetin, Bromelain and Vitamin C on COVID-19 Patients","author":"Ahmed","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174615_bib3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174615_bib4","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.xcrm.2020.100142","article-title":"Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.ejphar.2021.174615_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100701","article-title":"Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells","volume":"296","author":"Carpinteiro","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174615_bib6","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/molecules21121739","article-title":"Effects of quercetin in a rat model of hemorrhagic traumatic shock and reperfusion","volume":"21","author":"Chamorro","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2021.174615_bib7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3389\/fimmu.2020.01451","article-title":"Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)","volume":"11","author":"Colunga Biancatelli","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.174615_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00705-021-04956-9","article-title":"Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study","volume":"166","author":"Dabbous","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejphar.2021.174615_bib9","first-page":"1","article-title":"Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: a randomised controlled trial","volume":"11","author":"Dabbous","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174615_bib10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ptr.6887","article-title":"A role for quercetin in coronavirus disease 2019 (COVID\u201019)","volume":"35","author":"Derosa","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2021.174615_bib11","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/IJGM.S318720","article-title":"Possible therapeutic effects of adjuvant quercetin supplementation against early-stage COVID-19 infection: a prospective, randomized, controlled, and open-label study","volume":"14","author":"Di Pierro","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.ejphar.2021.174615_bib12","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2147\/IJGM.S318949","article-title":"Potential clinical benefits of quercetin in the early stage of COVID-19: results of a second, pilot, randomized, controlled and open-label clinical trial","volume":"14","author":"Di Pierro","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.ejphar.2021.174615_bib13","article-title":"Antivirals for COVID-19: A critical review","author":"Frediansyah","year":"2020","journal-title":"Clinical Epidemiology and global health"},{"key":"10.1016\/j.ejphar.2021.174615_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/biomedicines8050129","volume":"8","author":"Glinsky","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2021.174615_bib15","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174615_bib16","first-page":"1","article-title":"Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study","author":"Hoertel","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2021.174615_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.2317","article-title":"Association between FIASMAs and reduced risk of intubation or death in individuals hospitalized for severe COVID\u201019: an observational multicenter study","author":"Hoertel","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.174615_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The lancet"},{"key":"10.1016\/j.ejphar.2021.174615_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174615_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/M20-8148","article-title":"Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians Practice Points","volume":"174","author":"Kaka","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2021.174615_bib21","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ejphar.2021.174615_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu8030167","article-title":"Quercetin, inflammation and immunity","volume":"8","author":"Li","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2021.174615_bib23","series-title":"Cytokine Storms: Understanding COVID-19","author":"Mangalmurti","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174615_bib24","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3390\/ijms22094794","article-title":"Metabolic signatures associated with severity in hospitalized COVID-19 patients","volume":"22","author":"Mar\u00edn-Corral","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174615_bib25","series-title":"Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard","author":"Moon","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174615_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02037","article-title":"The immune response and immunopathology of COVID-19","volume":"11","author":"Mortaz","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.174615_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.resinv.2020.08.001","article-title":"Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: a report of 11 cases","volume":"58","author":"Murohashi","year":"2020","journal-title":"Respiratory investigation"},{"key":"10.1016\/j.ejphar.2021.174615_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","article-title":"COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"53","author":"Nile","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2021.174615_bib29","article-title":"Treatment of COVID-19 patients with quercetin: a prospective, single-centre, randomized, controlled trial","author":"Onal","year":"2021","journal-title":"Authorea Preprints"},{"key":"10.1016\/j.ejphar.2021.174615_bib30","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3390\/ijms21072412","article-title":"Partners in crime: the interplay of proteins and membranes in regulated necrosis","volume":"21","author":"Ros","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174615_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-021-00268-6","article-title":"Anti-inflammatory potential of Quercetin in COVID-19 treatment","volume":"18","author":"Saeedi-Boroujeni","year":"2021","journal-title":"J. Inflamm."},{"key":"10.1016\/j.ejphar.2021.174615_bib32","series-title":"Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19, Open Forum Infectious Diseases","author":"Seftel","year":"2021"},{"key":"10.1016\/j.ejphar.2021.174615_bib33","first-page":"1","article-title":"Efficacy and safety of favipiravir in moderate COVID-19 pneumonia patients without oxygen therapy: a randomized, phase III clinical trial","author":"Shinkai","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ejphar.2021.174615_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048416","article-title":"Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2021","journal-title":"BMJ open"},{"key":"10.1016\/j.ejphar.2021.174615_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-021-01577-1","article-title":"Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case\u2013control study","volume":"18","author":"Ucan","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.ejphar.2021.174615_bib36","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2020.01580","article-title":"Severe COVID-19: NLRP3 inflammasome dysregulated","volume":"11","author":"van den Berg","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.174615_bib37","series-title":"The NLRP3 Inflammasome and COVID-19: Activation, Pathogenesis and Therapeutic Strategies","author":"Zhao","year":"2021"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:16:52Z","timestamp":1762143412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921007718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"alternative-id":["S0014299921007718"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174615","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174615"}}